PROSTATE CANCER METASTATIC DISEASE
Clinical trials for PROSTATE CANCER METASTATIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER METASTATIC DISEASE trials appear
Sign up with your email to follow new studies for PROSTATE CANCER METASTATIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scan agent shows promise for spotting prostate cancer
Diagnosis CompletedThis study tested a new radioactive imaging agent called 68Ga-OncoACP3 in 20 men with prostate cancer. The goal was to see if it is safe and how much radiation the body receives. The agent helps doctors see cancer spots that other scans might miss.
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Diagnosis
Last updated May 13, 2026 16:01 UTC
-
Could a common ED drug shield cancer patients from chemo nerve pain?
Prevention CompletedThis study tested whether tadalafil, a drug often used for erectile dysfunction, can prevent nerve damage caused by docetaxel chemotherapy in men with metastatic prostate cancer. About 90 participants took either tadalafil every two days or standard care during their chemo. The g…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Tri-Service General Hospital • Aim: Prevention
Last updated May 17, 2026 01:52 UTC